Drugs / IPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06114810 Comparator | Nov 2023 → Jun 2024 | poliomyelitis | International Centre for Diarrhoeal Disease Research, Bangladesh | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06114810 ↗ |
| Modality | Vaccine | “Three polio vaccines will be used in the study: bOPV, nOPV2 and IPV in different sequential or combination schedules.” NCT06114810 ↗ |